Professor Gu Zhen and their team of student researchers at the Zhejiang University College of Pharmaceutical Sciences in Zhejiang, China are working tirelessly to push boundaries and innovate in the field of pharmaceutical sciences. The desire for independence from the West has been a driving force behind their efforts, as highlighted by President Xi Jinping’s strong stance on being self-reliant in critical technologies like microchips.
The long-standing anxieties among Chinese Communist Party leaders about being too reliant on American and Western high-tech imports have led to increased research and development within China. This move was further confirmed when President Trump imposed restrictions on Huawei, a telecoms giant, purchasing U.S. tech in 2019. Despite challenges and restrictions imposed by Western powers, Professor Gu Zhen’s team remains focused on advancing technology and innovation within China.
Their dedication and hard work are evident in the groundbreaking research being conducted at the college, which is paving the way for a future where China can stand on its own in the realm of high-tech innovation. As CCP leaders continue to emphasize the importance of being self-reliant, Professor Gu Zhen’s team will likely continue to play a key role in pushing boundaries and innovating within this area of research.
